Search the MBS

Standard Search

Advanced Search Search Tips

Enter keywords or item numbers below
Search Options

Results 11 to 20 of 46 matches

Category 5 - DIAGNOSTIC IMAGING SERVICES

61333

61333 - Additional Information

Item Start Date:
14-Sep-2019
Description Updated:
01-Mar-2021
Schedule Fee Updated:
14-Sep-2019

Group
I4 - Nuclear Medicine Imaging
Subgroup
1 - Nuclear medicine - non PET

Lung perfusion study and lung ventilation study using galligas or 68Ga-MAA, with PET (R)

Item 61333 was available from 1 December 2020 until 28 February 2021, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Determination 2019 on the Federal Register of Legislation for further information.

Bulk bill incentive



Fee: $443.35 Benefit: 75% = $332.55 85% = $376.85

Category 5 - DIAGNOSTIC IMAGING SERVICES

61336

61336 - Additional Information

Item Start Date:
14-Sep-2019
Description Updated:
01-Mar-2021
Schedule Fee Updated:
14-Sep-2019

Group
I4 - Nuclear Medicine Imaging
Subgroup
1 - Nuclear medicine - non PET

Cerebral perfusion study, with PET (R)

Item 61336 was available from 1 December 2020 until 28 February 2021, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Determination 2019 on the Federal Register of Legislation for further information.

Bulk bill incentive



Fee: $605.05 Benefit: 75% = $453.80 85% = $517.15

Category 5 - DIAGNOSTIC IMAGING SERVICES

61337

61337 - Additional Information

Item Start Date:
14-Sep-2019
Description Updated:
01-Mar-2021
Schedule Fee Updated:
14-Sep-2019

Group
I4 - Nuclear Medicine Imaging
Subgroup
1 - Nuclear medicine - non PET

Bone study—whole body, with PET, when undertaken, blood flow, blood pool and delayed imaging on a separate occasion (R)

Item 61337 was available from 1 December 2020 until 28 February 2021, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Determination 2019 on the Federal Register of Legislation for further information.

Bulk bill incentive



Fee: $479.80 Benefit: 75% = $359.85 85% = $407.85

Category 5 - DIAGNOSTIC IMAGING SERVICES

61341

61341 - Additional Information

Item Start Date:
14-Sep-2019
Description Updated:
01-Mar-2021
Schedule Fee Updated:
14-Sep-2019

Group
I4 - Nuclear Medicine Imaging
Subgroup
1 - Nuclear medicine - non PET

Bone study—whole body and PET, with, when undertaken, blood flow, blood pool and delayed imaging on a separate occasion (R)

Item 61341 was available from 1 December 2020 until 28 February 2021, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Determination 2019 on the Federal Register of Legislation for further information.

Bulk bill incentive



Fee: $600.70 Benefit: 75% = $450.55 85% = $512.80

Category 5 - DIAGNOSTIC IMAGING SERVICES

61365

61365 - Additional Information

Item Start Date:
01-Dec-2020
Description Updated:
01-Mar-2021
Schedule Fee Updated:
01-Dec-2020

Group
I4 - Nuclear Medicine Imaging
Subgroup
1 - Nuclear medicine - non PET

Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1

Repeat combined stress and rest, stress and re‑injection or rest and redistribution myocardial perfusion study, including delayed imaging or re‑injection protocol on a subsequent occasion, with PET, if:

(a) in the previous 24 months, the patient has had a service performed to which item 61311, 61324, 61329, 61332, 61345, 61357, 61377, 61380, 61394, 61398, 61406 or 61414 applies and has subsequently undergone a revascularisation procedure; and

(b) the patient has one or more symptoms of cardiac ischaemia that have evolved and are not adequately controlled with optimal medical therapy; and

(c) at least one of the following applies:

  1. the patient has body habitus or other physical conditions (including heart rhythm disturbance) to the extent that a stress echocardiography would not provide adequate information;
  2. the patient is unable to exercise to the extent required for a stress echocardiography to provide adequate information;
  3. the patient has had a failed stress echocardiography provided in a service to which item 55141, 55143, 55145 or 55146 applies; and

(d) the service is requested by a specialist or a consultant physician; and

(e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61349, 61410 or 61418 applies

Applicable not more than once in 12 months (R)

Item 61365 was available from 1 December 2020 until 28 February 2021, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Determination 2019 on the Federal Register of Legislation for further information.

Bulk bill incentive



Fee: $982.05 Benefit: 75% = $736.55 85% = $894.15

(See para IN.0.19, IN.4.3 of explanatory notes to this Category)

Category 5 - DIAGNOSTIC IMAGING SERVICES

61377

61377 - Additional Information

Item Start Date:
01-Dec-2020
Description Updated:
01-Mar-2021
Schedule Fee Updated:
01-Dec-2020

Group
I4 - Nuclear Medicine Imaging
Subgroup
1 - Nuclear medicine - non PET

Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1

Single stress myocardial perfusion study, with PET, if:

(a) the patient has symptoms of cardiac ischaemia; and

(b) the service is provided at, or from, a practice located in a Modified Monash 3, 4, 5, 6 or 7 area; and

(c) a stress echocardiography service is not available in the Modified Monash area where the service is provided; and

(d) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and

(e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61311, 61321, 61324, 61325, 61329, 61332, 61345, 61357, 61380, 61394, 61398, 61406, 61414 or 61422 applies

Applicable not more than once in 24 months (R)

Item 61377 was available from 1 December 2020 until 28 February 2021, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Determination 2019 on the Federal Register of Legislation for further information.

Bulk bill incentive



Fee: $653.05 Benefit: 75% = $489.80 85% = $565.15

(See para IN.0.19 of explanatory notes to this Category)

Category 5 - DIAGNOSTIC IMAGING SERVICES

61380

61380 - Additional Information

Item Start Date:
01-Dec-2020
Description Updated:
01-Mar-2021
Schedule Fee Updated:
01-Dec-2020

Group
I4 - Nuclear Medicine Imaging
Subgroup
1 - Nuclear medicine - non PET

Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1

Combined stress and rest, stress and re‑injection or rest and redistribution myocardial perfusion study, including delayed imaging or re‑injection protocol on a subsequent occasion, with PET, if:

(a) the patient has symptoms of cardiac ischaemia; and

(b) the service is provided at, or from, a practice located in a Modified Monash 3, 4, 5, 6 or 7 area; and

(c) a stress echocardiography service is not available in the Modified Monash area where the services is provided; and

(d) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and

(e) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61311, 61321, 61324, 61325, 61329, 61332, 61345, 61357, 61377, 61394, 61398, 61406, 61414 or 61422 applies

Applicable not more than once in 24 months (R)

Item 61380 was available from 1 December 2020 until 28 February 2021, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Determination 2019 on the Federal Register of Legislation for further information.

Bulk bill incentive



Fee: $982.05 Benefit: 75% = $736.55 85% = $894.15

(See para IN.0.19 of explanatory notes to this Category)

Category 5 - DIAGNOSTIC IMAGING SERVICES

61418

61418 - Additional Information

Item Start Date:
01-Dec-2020
Description Updated:
01-Mar-2021
Schedule Fee Updated:
01-Dec-2020

Group
I4 - Nuclear Medicine Imaging
Subgroup
1 - Nuclear medicine - non PET

Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.1

Repeat combined stress and rest, stress and re‑injection or rest and redistribution myocardial perfusion study, including delayed imaging or re‑injection protocol on a subsequent occasion, with PET, if:

(a) in the previous 24 months, the patient has had a service performed to which item 61311, 61324, 61329, 61332, 61345, 61357, 61377, 61380, 61394, 61398, 61406 or 61414 applies, and has subsequently undergone a revascularisation procedure; and

(b) the patient has one or more symptoms of cardiac ischaemia that have evolved and are not adequately controlled with optimal medical therapy; and

(c) the service is provided at, or from, a practice located in a Modified Monash 3, 4, 5, 6 or 7 area; and

(d) a stress echocardiography service is not available in the Modified Monash area where the service is provided; and

(e) the service includes resting electrocardiograph, continuous electrocardiograph monitoring during exercise (with recording), blood pressure monitoring and the recording of other parameters (including heart rate); and

(f) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61349, 61365 or 61410 applies

Applicable not more than once in 12 months (R)

Item 61418 was available from 1 December 2020 until 28 February 2021, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Determination 2019 on the Federal Register of Legislation for further information.

Bulk bill incentive



Fee: $982.05 Benefit: 75% = $736.55 85% = $894.15

(See para IN.0.19 of explanatory notes to this Category)

Category 5 - DIAGNOSTIC IMAGING SERVICES

61422

61422 - Additional Information

Item Start Date:
01-Dec-2020
Description Updated:
01-Mar-2021
Schedule Fee Updated:
01-Dec-2020

Group
I4 - Nuclear Medicine Imaging
Subgroup
1 - Nuclear medicine - non PET

Note: the service only applies if the patient meets the requirements of the descriptor and the requirements of Note: IR.4.2

Single rest myocardial perfusion study for the assessment of the extent and severity of viable and non‑viable myocardium, with PET, if:

(a) the patient has left ventricular systolic dysfunction and probable or confirmed coronary artery disease; and

(b) technetium is not available and the service uses an equivalent protocol to the single rest technetium‑99m (Tc‑99m) protocol; and

(c) the service is requested by a specialist or a consultant physician; and

(d) the service is not associated with a service to which item 11704, 11705, 11707, 11714, 11729, 11730, 61311, 61321, 61324, 61325, 61329, 61332, 61345, 61357, 61377, 61380, 61394, 61398, 61406 or 61414 applies

Applicable not more than once in 24 months (R)

Item 61422 was available from 1 December 2020 until 28 February 2021, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Determination 2019 on the Federal Register of Legislation for further information.

Bulk bill incentive



Fee: $329.00 Benefit: 75% = $246.75 85% = $279.65

(See para IN.0.19, IN.4.1, IR.4.2 of explanatory notes to this Category)

Category 5 - DIAGNOSTIC IMAGING SERVICES

61523

61523 - Additional Information

Item Start Date:
01-Jul-2018
Description Updated:
22-Dec-2005
Schedule Fee Updated:
01-Oct-2001

Group
I4 - Nuclear Medicine Imaging
Subgroup
2 - PET

Whole body FDG PET study, performed for evaluation of a solitary pulmonary nodule where the lesion is considered unsuitable for transthoracic fine needle aspiration biopsy, or for which an attempt at pathological characterisation has failed.(R)

Bulk bill incentive



Fee: $953.00 Benefit: 75% = $714.75 85% = $865.10

(See para IN.0.19 of explanatory notes to this Category)

Results 11 to 20 of 46 matches


Legend

  • Assist - Addition/Deletion of (Assist.)
  • Amend - Amended Description
  • Anaes - Anaesthetic Values Amended
  • Emsn - EMSN Change
  • Fee - Fee Amended
  • Renum - Item Number Change (renumbered)
  • New - New Item
  • NewMin - New Item (previous Ministerial Determination)
  • Qfe - QFE Change